These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2260046)

  • 1. [Beta-blockers and migraine. Efficacy of time-release propranolol versus placebo].
    Pradalier A; Serratrice G; Collard M; Hirsch E; Feve J; Masson M; Masson C; Dry J; Koulikovsky G; Nguyen G
    Therapie; 1990; 45(5):441-5. PubMed ID: 2260046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study.
    Pradalier A; Serratrice G; Collard M; Hirsch E; Feve J; Masson M; Masson C; Dry J; Koulikovsky G; Nguyen G
    Cephalalgia; 1989 Dec; 9(4):247-53. PubMed ID: 2692838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study.
    Gerber WD; Schellenberg R; Thom M; Haufe C; Bölsche F; Wedekind W; Niederberger U; Soyka D
    Funct Neurol; 1995; 10(1):27-35. PubMed ID: 7649498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the effect of 5-hydroxytryptophan and propranolol in the interval treatment of migraine].
    Maissen CP; Ludin HP
    Schweiz Med Wochenschr; 1991 Oct; 121(43):1585-90. PubMed ID: 1947955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
    Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
    Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
    Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine.
    Gawel MJ; Kreeft J; Nelson RF; Simard D; Arnott WS
    Can J Neurol Sci; 1992 Aug; 19(3):340-5. PubMed ID: 1393843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.
    Goadsby PJ; Ferrari MD; Csanyi A; Olesen J; Mills JG;
    Cephalalgia; 2009 Jul; 29(7):742-50. PubMed ID: 19222510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerance of cyclandelate versus pizotifen in the prophylaxis of migraine.
    Mastrosimone F; Iaccarino C; de Caterina G
    J Med; 1992; 23(1):1-16. PubMed ID: 1573338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C; Romanet JP; Nordmann JP; Allaire C;
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
    Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
    Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol].
    Wörz R; Reinhardt-Benmalek B; Föh M; Grotemeyer KH; Scharafinski HW
    Fortschr Med; 1992 May; 110(14):268-72. PubMed ID: 1351025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting propranolol in the prophylaxis of migraine: a comparative study of two doses.
    Carroll JD; Reidy M; Savundra PA; Cleave N; McAinsh J
    Cephalalgia; 1990 Apr; 10(2):101-5. PubMed ID: 2193712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of juvenile migraine using flunarizine or propranolol].
    Lütschg J; Vassella F
    Schweiz Med Wochenschr; 1990 Nov; 120(46):1731-6. PubMed ID: 2251492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study.
    Honkaniemi J; Liimatainen S; Rainesalo S; Sulavuori S
    Headache; 2006 May; 46(5):781-7. PubMed ID: 16643581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.